These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12536939)

  • 1. [Synthesis on the treatments of infiltrating tumors of the bladder].
    Bouchot O; Zerbib M
    Prog Urol; 2002 Nov; 12(5):1143-57. PubMed ID: 12536939
    [No Abstract]   [Full Text] [Related]  

  • 2. Bladder cancer markers. Current availability and the future standard of care.
    Sawczuk IS; Burchardt T; Shabsigh A; de la Taille A; Burchardt M
    MLO Med Lab Obs; 2000 Mar; 32(3):30-3, 36, 38 passim; quiz 42-4. PubMed ID: 10947451
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatments in invasive bladder cancer].
    Bouchot O; Zerbib M
    Prog Urol; 2003 Dec; 13(6):1415-27. PubMed ID: 15000325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [What's new in 2008 in the field of basic and clinical research in bladder cancer?].
    Phé V; Rouprêt M; Irani J
    Prog Urol; 2009 May; 19 Suppl 2():S43-50. PubMed ID: 19447328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Post-therapeutic surveillance of infiltrating tumors of the bladder].
    Zerbib M; Bouchot O
    Prog Urol; 2002 Nov; 12(5):1135-6. PubMed ID: 12536938
    [No Abstract]   [Full Text] [Related]  

  • 6. Extra-adrenal pheochromocytoma (paraganglioma) of the urinary bladder: a case report.
    Minagawa T; Sato T; Furuhata M; Hirabayashi N; Kato H
    Hinyokika Kiyo; 2004 Nov; 50(11):787-90. PubMed ID: 15628539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bladder tumors: current prognostic factors].
    Sohet X
    Acta Urol Belg; 1995 Mar; 63(1):61-71. PubMed ID: 7725994
    [No Abstract]   [Full Text] [Related]  

  • 8. [Case of small cell carcinoma of the urinary bladder effectively treated with adjuvant chemotherapy and radiotherapy following TUR].
    Okuda Y; Mori Y; Katoh Y; Iguchi M; Katoh M; Yamazaki D
    Hinyokika Kiyo; 2009 May; 55(5):267-9. PubMed ID: 19507545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases.
    Guo CC; Gomez E; Tamboli P; Bondaruk JE; Kamat A; Bassett R; Dinney CP; Czerniak BA
    Hum Pathol; 2009 Oct; 40(10):1448-52. PubMed ID: 19454359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Definition of specific protein patterns for advanced (metastatic) urinary bladder tumors for individual prognosis determination and treatment choice].
    Junker K; Pilchowski R; Stöhr R; von Eggeling F; Schubert J; Hartmann A
    Urologe A; 2007 Sep; 46(9):1288. PubMed ID: 17593341
    [No Abstract]   [Full Text] [Related]  

  • 11. [Non-epithelial tissue tumors of the urinary bladder].
    Xu AX; Wang XX; Hong BF; Ye LY; Zhang L
    Zhonghua Wai Ke Za Zhi; 2003 Jul; 41(7):530-3. PubMed ID: 12921662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of urinary bladder cancers].
    Romics I
    Orv Hetil; 2005 Sep; 146(39):2033-6. PubMed ID: 16265873
    [No Abstract]   [Full Text] [Related]  

  • 13. [Multiple paraganglioma of the urinary bladder].
    Kita M; Okuyama M; Azumi M; Hashimoto H; Kakizaki H
    Hinyokika Kiyo; 2007 Oct; 53(10):707-11. PubMed ID: 18018587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary large cell neuroendocrine carcinoma of the urinary bladder.
    Lee KH; Ryu SB; Lee MC; Park CS; Juhng SW; Choi C
    Pathol Int; 2006 Nov; 56(11):688-93. PubMed ID: 17040293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of stage T1 tumors of the bladder: International Consensus Panel.
    Nieder AM; Brausi M; Lamm D; O'Donnell M; Tomita K; Woo H; Jewett MA
    Urology; 2005 Dec; 66(6 Suppl 1):108-25. PubMed ID: 16399419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma.
    Paner GP; McKenney JK; Epstein JI; Amin MB
    Am J Surg Pathol; 2008 Jul; 32(7):1022-8. PubMed ID: 18469707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node density: surrogate marker for quality of resection in bladder cancer?
    Kamat AM; Fisher MB
    Expert Rev Anticancer Ther; 2007 Jun; 7(6):777-9. PubMed ID: 17555386
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder.
    Thomas AA; Stephenson AJ; Campbell SC; Jones JS; Hansel DE
    Hum Pathol; 2009 Jan; 40(1):108-16. PubMed ID: 18789486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.
    Shariat SF; Tokunaga H; Zhou J; Kim J; Ayala GE; Benedict WF; Lerner SP
    J Clin Oncol; 2004 Mar; 22(6):1014-24. PubMed ID: 14981102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T1G3 bladder cancer: conservative management or cystectomy?
    Gattegno B
    Eur Urol; 2004 Apr; 45(4):399-400. PubMed ID: 15041100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.